With increased longevity of patients suffering from cystic fibrosis, and widespread
lung transplantation facilities, the sequelae of defective CFTR in other organs than
the airways come to the fore. This minireview highlights recent scientific progress
in the understanding of CFTR function in the pancreas, the intestine and the kidney,
and explores potential therapeutic strategies to combat defective CFTR function in
these organs.
